A Trial of Episil® Oral Liquid in Cancer Patients Suffering From Chemotherapy- and/or Radiation-induced Oral Mucositis

NCT03546985 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy- and/or Radiation-induced Oral Mucositis

Interventions

DEVICE: episil®
DEVICE: Kang Su

Sponsor

Solasia Pharma K.K.

Collaborators

[object Object]